Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Jan Grimm

Sloan Kettering Inst Can Research, Department: Na

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Nortis Bio

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

See uploaded report.

Listed Research Project
Smart and self-reporting clinical nano carriers for drug delivery

PROJECT NARRATIVE AND RELEVANCE TO PUBLIC HEALTH Side effect and toxicity are undesired effects of cancer therapy, often destructive to the patient's quality of life. Nanoparticles have been used as delivery agents for drugs to resolve these issues but have faced significant shortcomings, e.g. achieving tailored activated release is considered as a key barrier in the field of nanoparticle-based drug delivery. Here, we explore a new delivery system based on clinically approved nanoparticles that can increase drug efficacy without increasing unwanted side effects and report the deployment of the drugs in the tumor through imaging. This new approach will provide valuable insight into the in vivo kinetics of nanocarrier and drug that cannot be obtained otherwise and will allow tailoring of nanocarrier-based drug delivery to the individual patient.

Filed on March 13, 2017.

Tell us what you know about Jan Grimm's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Jan Grimm Sloan Kettering Inst Can Research Conflict of Interest Nortis Bio Value cannot be readily determined
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page